Wyeth said thisweek that it would begin shipping an authorized generic version of Protonix(pantoprazole), its ulcer drug, through Prasco. The shipmentsfollow the at-risk launch of generic pantoprazole ...

Wyeth and its Swiss partner Nycomed have announced the launch in the USA of a generic version of the blockbuster Protonix in the latest stage of a battle with Teva Pharmaceutical Industries concerning ...

Pantoprazole (P-40) is a proton-pump inhibitor, prescribed for gastroesophageal reflux disease (GERD), ulcers, Zollinger-Ellison Syndrome, and erosive esophagitis. It decreases the amount of acid made ...

NORTH WALES, Pa. Teva has launched its newest drug, a generic version of the Wyeth acid reflux drug Protonix. The drug is named Pantoprazole Sodium Delayed-Release. The drug will be available in both ...

TORONTO, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced that it has notified the U.S. Food and Drug Administration (FDA) that it has ...

August 10, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for dantrolene sodium injectable 20 mg/vial for the management of malignant hyperthermia; ...

TEL AVIV, Dec 24 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd on Monday raised its 2007 earnings outlook due to the launch of its generic version of Wyeth's ulcer drug Protonix. The product ...

NEW YORK (AP) -- Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...

Switzerland-based Nycomed has posted a dip in first-quarter sales due to generic competition to the gastrointestinal drug pantoprazole in the USA but chief executive Hakan Bjorklund told PharmaTimes ...

Pantoprazole (P-BIT) is a proton-pump inhibitor, prescribed for gastroesophageal reflux disease (GERD), ulcers, Zollinger-Ellison Syndrome, and erosive esophagitis. It decreases the amount of acid ...